Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients Undergoing Colonoscopy

September 12, 2017 updated by: Yanglin Pan, Air Force Military Medical University, China

Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients

Adequate quality of bowel preparation(BP) is important for colonoscopy. Several guidelines recommend that split-dose of 4L PEG should be used as a standard regime for BP. However, the high-volume PEG still results in lower compliance to the regime and increased cost.

Some high risk factors for inadequate BP have been identified, including old age, constipation, diabetes, the use of narcotics and prior history of inadequate BP. For average-risk patients without the high risk factors, the procedure of BP could be easier. In the previous study, with the use of single dose of 2L PEG, more than 90% of average-risk patients achieved adequate BP. Here investigators hypothesized that compared with the standard split dose of 4L PEG, single dose of 2L PEG may be not inferior in BP quality while may be accompanied with better tolerability.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

940

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Qinghai
      • Xining, Qinghai, China, 810000
        • Department of gastroenterology, Qinghai Provincial People's Hospital
    • Shaanxi
      • Xi'an, Shaanxi, China, 710032
        • Department of gastroenterology, Shaanxi Second People's Hospital
    • Shanxi
      • Xi'an, Shanxi, China, 710032
        • Endoscopic center, Xijing Hospital of Digestive Diseases

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing colonoscopy;
  • Patients with average risks for inadequate BP (Patients were identified average-risk if they did not meet any factor of the following risk factors):

    • Constipation
    • Diabetes
    • Parkinson's disease
    • History of stroke or spine cord injure
    • Prior history of inadequate bowel preparation
    • BMI>25
    • Use of tricyclic antidepressant or narcotics

Exclusion Criteria:

  • History of colorectal resection;
  • Suspected colonic stricture or perforation;
  • Incomplete or complete bowel obstruction;
  • Use of prokinetic agents or purgatives within 7 days;
  • Toxic colitis or megacolon;
  • Pregnancy or lactation;
  • Unable to give informed consent;
  • Haemodynamically unstable.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single dose of 2L PEG
2 L of PEG solution was used on the day of colonoscopy.
Patients at average risk for inadequate BP were given instructions for bowel preparation through phone call a day before scheduled colonoscopy. Patients began to drink 2 L of PEG 4-6 hours before colonoscopy at a rate of 250 mL every 15 minutes.
Active Comparator: Split-dose of 4L PEG
Split-dose of 4l PEG was used before and on the day of colonoscopy
All patients at average risk for inadequate BP were given instructions for bowel preparation through phone call a day before scheduled colonoscopy. the participants began to drink the first 2 L of PEG at 7:00-9:00 PM on the day before colonoscopy at a rate of 250 mL every 15 minutes. On the day of the procedure, patients took the remaining 2 L 4-6 hours before colonoscopy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of adequate bowel preparation(defined as a total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2)
Time Frame: 1 year
The adequacy of bowel preparation is defined as Boston Bowel Preparation Scale (BBPS), a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. They were summed to give the total BBPS score, which ranged from 0 to 9.The withdrawal procedure was recorded by vedios. The BBPS and segmental scores in each segment were judged by one endoscopist who was familiar with the criteria of BBPS and blinded to group allocation.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Withdrawal time
Time Frame: 1 year
1 year
Polyp detection rate
Time Frame: 1 year
1 year
Rate of adverse events
Time Frame: 1 year
adverse events, such as vomiting, nausea, headache, abdominal pain
1 year
Cecal intubation rate
Time Frame: 1 year
1 year
Cecal intubation time
Time Frame: 1 year
1 year
Willingness to repeat bowel preparation
Time Frame: 1 year
The number of patients have a willingness to undergo a repeated bowel preparation if needed
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2016

Primary Completion (Actual)

August 1, 2017

Study Completion (Actual)

August 1, 2017

Study Registration Dates

First Submitted

November 30, 2016

First Submitted That Met QC Criteria

December 16, 2016

First Posted (Estimate)

December 20, 2016

Study Record Updates

Last Update Posted (Actual)

September 13, 2017

Last Update Submitted That Met QC Criteria

September 12, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • KY20162097-5

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Behavior

Clinical Trials on Single dose of 2L PEG

Subscribe